Recent searches
Search options
RT @JohnEbbenMDPhD
@TumorBoardTues @jane_meisel @quirogad @MPishvaian @BreastCaupdates @BreastCancerNow @TNBCFoundation @ArielleMedford @drteplinsky @EricaMarieRomn1 @jacobadashek @stolaney1 @MarkRobsonMD 4/5 #TumorBoardTuesday
Take
messages:
In HER2- mBC:
Germline genetics 
: ~5% of BC= BRCAm; 
% in #TNBC gBRCAm= PARPi preferred After PARPi, consider ADCs If PD-L1+ & gBRCAm negative, consider chemoIO
@jane_meisel @quirogad’s discussion:
https://threadreaderapp.com/thread/1605368723166355456.html
threadreaderapp.comThread by @quirogad on Thread Reader App@quirogad: @TumorBoardTues @jane_meisel @MPishvaian @JohnEbbenMDPhD 1/17 #TumorBoardTuesday #BreastCancer #OncTwitter @JasmineSukumar @DrGattiMays 👩🏽 65 yo post-menopausal 🚫comorbidities 🔺Triple-neg MBC, germline BR...…